$1.00
▼ -3.4% Today
as of Oct 22, 16:50 ET
Last 30 days
Recent Press Releases & News
Lisata adds biopharma finance veteran Jeffrey Farrow to board
Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
Lisata Therapeutics wins new US patent for pancreatic cancer drug
LSTA earnings at a glance
Lisata Therapeutics, Inc. (LSTA) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. Over its last 4 reports the stock rose the next day 1 time and fell 3, moving ±8.6% on average; after the most recent report on May 11, 2026 it moved +3.5%. LSTA beat the consensus EPS estimate in 2 of its last 3 reported quarters. The share price of $1.00 sits near its 52-week low.
Overview
52-week range
$0.96
$5.07
1% of range
Avg surprise (last 3)
+7.5%
Avg reaction (last 4)
-6.8%
25% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.32 | — | — | — | — | financials |
| Mon May 11, 2026 | Mar/2026 | $-0.50 | — | — | +9.1% | +3.5% | earnings |
| Thu Nov 6, 2025 | Sep/2025 | $-0.49 | $-0.54 | +9.3% | — | -12.3% | earnings |
| Thu Aug 7, 2025 | Jun/2025 | $-0.54 | $-0.65 | +16.9% | — | -7.1% | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.55 | $-0.53 | -3.8% | — | -11.4% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.59 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.61 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.65 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.65 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.50 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.77 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Nov 5, 2026 | Sep/2026 | OTHER | — | -$0.49 |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | $0 | $70,000 | $0 | — | $0 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | $-5M | — | $-4M | $-5M | $-6M | — | $-5M |
| Net income | $-3M | $-4M | — | $-4M | $-5M | $-5M | — | $-5M |
| EPS (diluted) | $-0.32 | $-0.50 | — | $-0.49 | $-0.54 | $-0.55 | — | $-0.59 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $10M | $13M | $16M | $19M | $17M | $20M | $16M | $20M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $11M | $14M | $18M | $22M | $25M | $29M | $35M | $38M |
| Total assets | $11M | $14M | $18M | $22M | $25M | $29M | $35M | $38M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $3M | $3M | $3M | $5M | $4M | $4M | $6M | $5M |
| Total equity | $8M | $11M | $15M | $17M | $21M | $25M | $30M | $33M |
Implied volatility — last 90 days
No IV snapshots yet for LSTA.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
LSTA earnings FAQ
When is LSTA's next earnings date?
Lisata Therapeutics, Inc. is expected to report on November 5, 2026.
How does LSTA stock usually react to earnings?
Across the last 4 reports the average next-day move was ±8.6%, up 1 times and down 3 times.